2nd Faculty of Medicine Department of Pathology Charles University and Motol University Hospital Prague Czech Republic

Department of Immunology and Hematology Assistance Publique Hopitaux de Paris Necker Children's Hospital Paris France

Department of Medicine University of Cambridge Cambridge United Kingdom

Department of Pediatrics National Defense Medical College Saitama Japan

Descartes Sorbonne Paris Cité University of Paris Imagine Institute Paris France; Department of Immunology and Hematology Assistance Publique Hopitaux de Paris Necker Children's Hospital Paris France; Center for Primary Immunodeficiencies Assistance Publique Hopitaux de Paris Necker Children's Hospital Paris France; Laboratory of Human Genetics of Infectious Diseases Necker Branch Necker Medical School Paris France

Descartes Sorbonne Paris Cité University of Paris Imagine Institute Paris France; Laboratory of Human Genetics of Infectious Diseases Necker Branch Necker Medical School Paris France; St Giles Laboratory of Human Genetics of Infectious Diseases Rockefeller Branch The Rockefeller University New York NY

King's College London King's Health Partners King's College Hospital NHS Foundation Trust School of Medicine Department of Histopathology Denmark Hill London United Kingdom

King's College London King's Health Partners King's College Hospital NHS Foundation Trust School of Medicine Division of Allergy Asthma and Lung Biology Department of Immunological Medicine Denmark Hill London United Kingdom

National Institute of Health and Medical Research Necker Children's Hospital Paris France; Descartes Sorbonne Paris Cité University of Paris Imagine Institute Paris France

National Institute of Health and Medical Research Necker Children's Hospital Paris France; Descartes Sorbonne Paris Cité University of Paris Imagine Institute Paris France; Department of Immunology and Hematology Assistance Publique Hopitaux de Paris Necker Children's Hospital Paris France

National Institute of Health and Medical Research Necker Children's Hospital Paris France; Descartes Sorbonne Paris Cité University of Paris Imagine Institute Paris France; Department of Immunology and Hematology Assistance Publique Hopitaux de Paris Necker Children's Hospital Paris France; Center for Primary Immunodeficiencies Assistance Publique Hopitaux de Paris Necker Children's Hospital Paris France

Regional Immunology Service The Royal Hospitals Queen's University Belfast United Kingdom

The Institute of Immunology University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Angulo I, Vadas O, Garcon F, Banham-Hall E, Plagnol V, Leahy TR, Baxendale H, Coulter T, Curtis J, Wu C, Blake-Palmer K, Perisic O, Smyth D, Maes M, Fiddler C, Juss J, Cilliers D, Markelj G, Chandra A, Farmer G, Kielkowska A, Clark J, Kracker S, Debre M, Picard C, Pellier I, Jabado N, Morris JA, Barcenas-Morales G, Fischer A, Stephens L, Hawkins P, Barrett JC, Abinun M, Clatworthy M, Durandy A, Doffinger R, Chilvers ER, Cant AJ, Kumararatne D, Okkenhaug K, Williams RL, Condliffe A, Nejentsev S. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342:866–871. PubMed PMC

Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, Avery DT, Moens L, Cannons JL, Biancalana M, Stoddard J, Ouyang W, Frucht DM, Rao VK, Atkinson TP, Agharahimi A, Hussey AA, Folio LR, Olivier KN, Fleisher TA, Pittaluga S, Holland SM, Cohen JI, Oliveira JB, Tangye SG, Schwartzberg PL, Lenardo MJ, Uzel G. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15:88–97. PubMed PMC

Kang S, Denley A, Vanhaesebroeck B, Vogt PK. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci U S A. 2006;103:1289–1294. PubMed PMC

Sander S, Calado DP, Srinivasan L, Kochert K, Zhang B, Rosolowski M, Rodig SJ, Holzmann K, Stilgenbauer S, Siebert R, Bullinger L, Rajewsky K. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell. 2012;22:167–179. PubMed PMC

Rickert RC. New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nat Rev Immunol. 2013;13:578–591. PubMed

Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2013;110:1398–1403. PubMed PMC

Webb HK, Chen H, Yu AS, Peterman S, Holes L, Lannutti B, Miller LL, Ulrich RG. Clinical Pharmacokinetics of CAL-101, a p110{delta} Isoform-Selective PI3K Inhibitor, Following Single- and Multiple-Dose Administration In Healthy Volunteers and Patients with Hematological Malignancies. Blood (ASH Annual meeting abstracts) 2010;116

Neven B, Mamessier E, Bruneau J, Kaltenbach S, Kotlarz D, Suarez F, Masliah-Planchon J, Billot K, Canioni D, Frange P, Radford-Weiss I, Asnafi V, Murugan D, Bole C, Nitschke P, Goulet O, Casanova JL, Blanche S, Picard C, Hermine O, Rieux-Laucat F, Brousse N, Davi F, Baud V, Klein C, Nadel B, Ruemmele F, Fischer A. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood. 2013;122:3713–3722. PubMed

Cunningham-Rundles C. How I treat common variable immune deficiency. Blood. 2010;116:7–15. PubMed PMC

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside

Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study